Skip to main content
Thirumalai Chemicals Ltd. logo

Thirumalai Chemicals Ltd. — Investor Relations & Filings

Ticker · TIRUMALCHM ISIN · INE338A01024 LEI · 335800MIJ2YH47XEXQ24 BSE.NS Manufacturing
Filings indexed 1,039 across all filing types
Latest filing 2026-05-30 Regulatory Filings
Country IN India
Listing BSE.NS TIRUMALCHM

About Thirumalai Chemicals Ltd.

https://thirumalaichemicals.com/

Thirumalai Chemicals Ltd. is a global manufacturer specializing in organic chemicals and intermediates. The company primarily produces Phthalic Anhydride, Maleic Anhydride, Fumaric Acid, and Malic Acid. These products serve as essential raw materials for diverse applications, including unsaturated polyester resins, alkyd resins, plasticizers, and food additives. With advanced manufacturing facilities, the company supplies high-purity chemical solutions to the plastics, coatings, pharmaceutical, and food sectors. It maintains a strong focus on process efficiency and technical excellence to support its international customer base across various industrial applications.

Recent filings

Filing Released Lang Actions
Annual Secretarial Compliance Report for year ended March 31, 2026
Regulatory Filings
2026-05-30 English
Please find attahed statement of deviation and variation in utilization of funds raised through prresential issue for the quarter ended March 31, 2026
Regulatory Filings Classification · 91% confidence The document is a compliance submission under SEBI (Listing Obligations and Disclosure Requirements) Regulation 32 reporting the “Statement of Deviation or Variation in utilization of funds raised” for the quarter ended March 31, 2026. It is a mandatory regulatory disclosure to the stock exchanges rather than a standalone financial report, earnings release, or capital raising announcement. It does not present full financial statements or actual financial results but fulfills a listing regulation requirement. This fits the definition of a general regulatory announcement/compliance document, which falls under the Regulatory Filings category (RNS).
2026-05-30 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 75% confidence The document is a compliance submission to the National Stock Exchange and BSE under SEBI LODR Regulation 32, providing a Statement of Deviation or Variation in utilization of funds raised via a preferential issue for the quarter ended March 31, 2026. It does not contain standalone financial statements, earnings data, or proxy material, nor is it announcing a new share issue; rather it is a regulatory disclosure under listing obligations. This falls under general regulatory filings (miscellaneous compliance announcements).
2026-05-30 English
Please find attached the financial results for the year ended March 31, 2026
Interim / Quarterly Report Classification · 87% confidence The document is an outcome of a Board Meeting filed under SEBI LODR Regulations 30 and 33, disclosing audited financial results for the quarter (Q4 ended March 31, 2026) along with year-to-date numbers and full financial statements (asset and liability sheet, P&L, notes). It is not merely a short earnings summary (ER), nor a full annual report (10-K), but a detailed interim/quarterly financial report as required under listing regulations. Therefore, it best fits the Interim / Quarterly Report category (IR). FY 2026
2026-05-30 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 88% confidence The document is a formal SEBI LODR submission of the board meeting outcome, presenting audited standalone and consolidated financial results (assets & liabilities, profit & loss, comprehensive income, notes) for the quarter and year ended March 31, 2026. It contains detailed actual financial statements rather than just highlights or an announcement that the report is attached. It is not a full Annual Report (10-K) nor merely an earnings press release; it is a comprehensive interim/quarterly (and year-end) financial report filed under listing regulations. Therefore, it best fits the “Interim / Quarterly Report” category (IR). FY 2026
2026-05-30 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 86% confidence The document is a stock‐exchange filing under SEBI LODR Regulations 30 & 33 dated May 30, 2026, titled “Outcome of the Board Meeting and Disclosures” which provides the audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2026, complete with detailed balance sheet, P&L and notes. It is not a press release of highlights (ER), nor a full annual report (10-K) or management discussion (MDA). It contains substantive financial data for an interim period (the March quarter), meeting the criteria for an Interim/Quarterly Report. Therefore, it should be classified as IR. FY 2026
2026-05-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.